Evidence map›Paper›PMID 42795447›Full record

ArticleMicroorganisms2026

Challenges in the Management of Hepatitis B Among Children and Adolescents: A 10-Year Single-Center Experience.

Anna Dobrzeniecka, Ewa Talarek, Małgorzata Aniszewska, Barbara Kowalik-Mikołajewska, Agnieszka Ołdakowska, Beata Krynicka-Czech, Magdalena Marczyńska, Maria Pokorska-Śpiewak

Abstract read
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna DobrzenieckaDepartment of Children's Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0003-1731-2329
Ewa TalarekDepartment of Children's Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0002-3466-0782
Małgorzata AniszewskaDepartment of Children's Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.
Barbara Kowalik-MikołajewskaDepartment of Children's Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.
Agnieszka OłdakowskaDepartment of Children's Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0002-1329-8112
Beata Krynicka-CzechPediatric Infectious Diseases Department, Regional Hospital of Infectious Diseases in Warsaw, 01-201 Warsaw, Poland.
Magdalena MarczyńskaDepartment of Children's Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0001-5731-6346
Maria Pokorska-ŚpiewakDepartment of Children's Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0001-7783-6904

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following successful neonatal HBV vaccination and perinatal screening, pediatric hepatitis B has become uncommon in Central Europe. However, migration and complex clinical scenarios are reshaping its epidemiology. We aimed to characterize the clinical course, disease phases, and treatment eligibility of children with HBV infection. This retrospective single-center study included patients aged 0 to <18 years referred to a tertiary pediatric infectious diseases center in Warsaw, Poland, between January 2016 and June 2026. Demographic, clinical, and laboratory data were analyzed, and patients were classified according to the 2025 EASL guidelines. Sixteen children were included. New referrals tripled from 2016-2020 (

Indexed as

childrenchronic hepatitis B (CHB)occult hepatitis B (OBI)

Identifiers

PMID42795447
PMCPMC13609123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.